Skip to content

Management of Hair fall and other scalp conditions

A prospective randomized double blind study to evaluate clinical efficacy and safety of Lotion + Multivitamin Tablets in the management of hair fall and other scalp conditions

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/07/002825
Enrollment
75
Registered
2012-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Complaints of hair fall and other hair and scalp conditions

Interventions

Intervention1: Tricologic Lotion Plus Tablets: Herbal Lotion Apply about 1 to 2 ml once or twice daily for 12 weeks Multiple Nutritional Tablets 1 Tablet twice daily for 12 weeks Control Interventi

Sponsors

Meyer Organic Pvt Ltd Thane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and female subjects aged 18 to 50 years with complaints of hair fall and other hair conditions 2.Individuals who are willing to give informed consent and willing to follow/adhere to the study protocol 3.Willing to refrain from any other treatment for the main indications for which the study drugs are being given during the course of the study

Exclusion criteria

Exclusion criteria: 1.Subjects who have applied topical treatment for hair loss for at least 4 weeks and any systemic treatment for at least 3 months, prior to their participation in the study. 2.Subjects on a course of other treatment, which affects the outcome of the study 3.Subjects who had hair chemically treated (including colored hair, permed hair, etc) within the month prior to the study 4.Subjects who are not willing to maintain a routine and consistent hair styling 5.Subjects who have plans of shaving of scalp hair during the course of the study. 6.Subjects who are on chronic oral steroids 7.Subjects with reported allergies to one or more ingredients of intervention product 8.Presence of irritated or visibly inflamed scalp or severe scalp disease

Design outcomes

Primary

MeasureTime frame
Improvement in Hair Fall & other hair and scalp conditionsTimepoint: Baseline Day 30 60 and 90

Secondary

MeasureTime frame
Improvement in quality of hairs and scalp Subjects Satisfaction with Treatment Investigator Global Assessment of Treatment EfficacyTimepoint: Baseline Day 30 60 and 90

Countries

India

Contacts

Public ContactOnkar Rathod

KIMS, HUBLI

raghutoph@gmail.com09448051470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026